FIGURE

FIGURE 2

ID

ZDB-FIG-250513-77

Publication

Lv et al., 2025 - Apigenin promotes melanogenesis and melanosome transport through the c-KIT/Raf-1/MAPK/CREB pathway in HEMCs

Other Figures

All Figure Page

Back to All Figure Page

FIGURE 2

Apigenin increases cellular tyrosinase activity and expression of melanogenic proteins. (A) Cellular tyrosinase activity was measured after treatment with apigenin (0, 1, 5, or 10 μM). (B) Mushroom tyrosinase activity was measured in a cell-free assay after treatment with apigenin (0, 1, 5, or 10 μM). (C) HEMCs were treated with apigenin (0, 1, 5, or 10 μM) for 48 h, and Western blotting was performed to assess protein levels of melanogenic markers. (D) Time-dependent changes in the expression levels of various proteins after treatment with apigenin (10 μM) for the indicated periods. (E) HEMCs were treated with apigenin (10 μM) for 4 h, and RT-qPCR was performed to measure MITF gene expression. (F) HEMCs were treated with apigenin (10 μM) for different time points, followed by Western blotting to assess MITF protein levels. Data are expressed as means ± SEM (n = 3). *p < 0.05, **p < 0.01, and ***p < 0.001 vs. untreated cells. HEMCs, human epidermal melanocytes; MITF, Melanocytes inducing transcription factor.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image.